1. Home
  2. EDSA vs DEVS Comparison

EDSA vs DEVS Comparison

Compare EDSA & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • DEVS
  • Stock Information
  • Founded
  • EDSA 2015
  • DEVS N/A
  • Country
  • EDSA Canada
  • DEVS Canada
  • Employees
  • EDSA N/A
  • DEVS N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • DEVS
  • Sector
  • EDSA Health Care
  • DEVS
  • Exchange
  • EDSA Nasdaq
  • DEVS NYSE
  • Market Cap
  • EDSA 6.2M
  • DEVS 6.1M
  • IPO Year
  • EDSA N/A
  • DEVS N/A
  • Fundamental
  • Price
  • EDSA $1.96
  • DEVS $0.49
  • Analyst Decision
  • EDSA Strong Buy
  • DEVS
  • Analyst Count
  • EDSA 1
  • DEVS 0
  • Target Price
  • EDSA $21.00
  • DEVS N/A
  • AVG Volume (30 Days)
  • EDSA 34.1K
  • DEVS 52.4M
  • Earning Date
  • EDSA 05-14-2025
  • DEVS 07-03-2025
  • Dividend Yield
  • EDSA N/A
  • DEVS N/A
  • EPS Growth
  • EDSA N/A
  • DEVS N/A
  • EPS
  • EDSA N/A
  • DEVS N/A
  • Revenue
  • EDSA N/A
  • DEVS N/A
  • Revenue This Year
  • EDSA N/A
  • DEVS N/A
  • Revenue Next Year
  • EDSA N/A
  • DEVS N/A
  • P/E Ratio
  • EDSA N/A
  • DEVS N/A
  • Revenue Growth
  • EDSA N/A
  • DEVS N/A
  • 52 Week Low
  • EDSA $1.55
  • DEVS $0.18
  • 52 Week High
  • EDSA $5.59
  • DEVS $3.00
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.93
  • DEVS N/A
  • Support Level
  • EDSA $1.96
  • DEVS N/A
  • Resistance Level
  • EDSA $2.06
  • DEVS N/A
  • Average True Range (ATR)
  • EDSA 0.10
  • DEVS 0.00
  • MACD
  • EDSA -0.00
  • DEVS 0.00
  • Stochastic Oscillator
  • EDSA 30.77
  • DEVS 0.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About DEVS DEVVSTREAM CORP

DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.

Share on Social Networks: